{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:08:25Z","timestamp":1792786105819,"version":"4.5.0"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":253,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"National Hospital Organization","id":[{"id":"https:\/\/ror.org\/03ntccx93","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,21]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Although newly developed immunosuppressive therapies have markedly enhanced disease control in patients with RA, they are associated with an increased risk of various infections, including nontuberculous mycobacterial (NTM) disease and tuberculosis (TB). The anti-glycopeptidolipid (GPL) antibody (Ab) test is used to screen for NTM disease, and the interferon-gamma release assay (IGRA) is used to screen for TB. However, detailed analyses of positive anti-GPL Ab test results from RA patients remain scarce. Therefore, this study examined anti-GPL Ab testing and IGRA positivity in RA patients to determine whether NTM or TB are increased in RA patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Clinical information of Japanese RA patients who underwent anti-GPL Ab testing from 2015 to 2023 or IGRA from 2013 to 2023 was analysed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The positivity rates of anti-GPL Ab testing were higher in female RA (P\u2009=\u20090.0211) and older RA (P\u2009=\u20090.0050) patients, and increased with time (P\u2009=\u20098.61\u2009\u00d7\u200910\u22128). The positivity rates of anti-GPL Ab testing in younger female RA patients showed a trend towards being increased. The positivity rates of IGRA decreased with time (P\u2009=\u20090.0015).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The positivity rates of anti-GPL Ab testing increased with time in RA patients and were higher in older RA or younger female RA patients, suggesting the increasing incidences of NTM diseases in Japanese RA patients. The positivity rates of IGRA decreased with time in RA patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rap\/rkag112","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T11:53:17Z","timestamp":1789041197000},"source":"Crossref","is-referenced-by-count":0,"title":["Nontuberculous mycobacterium seroprevalence in Japanese patients with RA"],"prefix":"10.1093","volume":"10","author":[{"given":"Yusuke","family":"Yano","sequence":"first","affiliation":[{"name":"Department of Rheumatology, NHO Sagamihara National Hospital , Sagamihara,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Nogi","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, NHO Sagamihara National Hospital , Sagamihara,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7894-6389","authenticated-orcid":false,"given":"Hirokazu","family":"Taguchi","sequence":"additional","affiliation":[{"name":"Department of Rheumatic Diseases, Tokyo Metropolitan Tama Medical Center , Fuchu,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Higuchi","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, NHO Tokyo National Hospital , Kiyose,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuminori","family":"Hirano","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, NHO Asahikawa Medical Center , Asahikawa,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shomi","family":"Oka","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, NHO Tokyo National Hospital , Kiyose,","place":["Japan"]},{"name":"Clinical Research Center for Allergy and Rheumatology, NHO Sagamihara National Hospital , Sagamihara,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kota","family":"Shimada","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, NHO Sagamihara National Hospital , Sagamihara,","place":["Japan"]},{"name":"Department of Rheumatic Diseases, Tokyo Metropolitan Tama Medical Center , Fuchu,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiro","family":"Matsui","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, NHO Sagamihara National Hospital , Sagamihara,","place":["Japan"]},{"name":"Clinical Research Center for Allergy and Rheumatology, NHO Sagamihara National Hospital , Sagamihara,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeto","family":"Tohma","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, NHO Tokyo National Hospital , Kiyose,","place":["Japan"]},{"name":"Clinical Research Center for Allergy and Rheumatology, NHO Sagamihara National Hospital , Sagamihara,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Itoh","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, NHO Tokyo National Hospital , Kiyose,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1353-8056","authenticated-orcid":false,"given":"Hiroshi","family":"Furukawa","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, NHO Tokyo National Hospital , Kiyose,","place":["Japan"]},{"name":"Clinical Research Center for Allergy and Rheumatology, NHO Sagamihara National Hospital , Sagamihara,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"key":"2026101605073634100_rkag112-B1","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1136\/rmdopen-2020-001235","article-title":"Risk for infections with glucocorticoids and DMARDs in patients with rheumatoid arthritis","volume":"7","author":"Riley","year":"2021","journal-title":"RMD Open"},{"key":"2026101605073634100_rkag112-B2","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.3201\/eid1510.090310","article-title":"Nontuberculous mycobacteria infections and anti-tumor necrosis factor-alpha therapy","volume":"15","author":"Winthrop","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"2026101605073634100_rkag112-B3","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.3201\/eid2206.151086","article-title":"Epidemiology of pulmonary nontuberculous mycobacterial disease, Japan","volume":"22","author":"Namkoong","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"2026101605073634100_rkag112-B4","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1513\/AnnalsATS.201607-573OC","article-title":"A laboratory-based analysis of nontuberculous mycobacterial lung disease in Japan from 2012 to 2013","volume":"14","author":"Morimoto","year":"2017","journal-title":"Ann Am Thorac Soc"},{"key":"2026101605073634100_rkag112-B5","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.resinv.2024.09.007","article-title":"Epidemiological trends and clinical relevance of nontuberculous mycobacterial pulmonary disease in a referral hospital in Japan, 2017-2021","volume":"62","author":"Ito","year":"2024","journal-title":"Respir Investig"},{"key":"2026101605073634100_rkag112-B6","doi-asserted-by":"crossref","first-page":"00337","DOI":"10.1183\/23120541.00337-2024","article-title":"Laboratory-based surveillance of nontuberculous mycobacterial pulmonary disease in Japan","volume":"11","author":"Hamaguchi","year":"2025","journal-title":"ERJ Open Res"},{"key":"2026101605073634100_rkag112-B7","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/nrrheum.2013.82","article-title":"Bedfellows: mycobacteria and rheumatoid arthritis in the era of biologic therapy","volume":"9","author":"Winthrop","year":"2013","journal-title":"Nat Rev Rheumatol"},{"key":"2026101605073634100_rkag112-B8","first-page":"6","article-title":"Prevalence and incident rate of non-tuberculous mycobacteriosis in patients with rheumatoid arthritis","volume":"78","author":"Katayama","year":"2017","journal-title":"NMC Res"},{"key":"2026101605073634100_rkag112-B9","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1164\/rccm.200705-771OC","article-title":"Serodiagnosis of Mycobacterium avium-complex pulmonary disease using an enzyme immunoassay kit","volume":"177","author":"Kitada","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"2026101605073634100_rkag112-B10","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1183\/09031936.00098212","article-title":"Serodiagnosis of Mycobacterium avium complex pulmonary disease in the USA","volume":"42","author":"Kitada","year":"2013","journal-title":"Eur Respir J"},{"key":"2026101605073634100_rkag112-B11","first-page":"547","article-title":"[Nontuberculous mycobacteriosis mortality in Japan]","volume":"86","author":"Morimoto","year":"2011","journal-title":"Kekkaku"},{"key":"2026101605073634100_rkag112-B12","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3109\/s10165-010-0368-5","article-title":"Serodiagnosis of Mycobacterium avium-complex pulmonary disease with an enzyme immunoassay kit that detects anti-glycopeptidolipid core antigen IgA antibodies in patients with rheumatoid arthritis","volume":"21","author":"Watanabe","year":"2011","journal-title":"Mod Rheumatol"},{"key":"2026101605073634100_rkag112-B13","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000354791","article-title":"Serodiagnosis of Mycobacterium avium complex pulmonary disease in rheumatoid arthritis","volume":"87","author":"Komazaki","year":"2014","journal-title":"Respiration"},{"key":"2026101605073634100_rkag112-B14","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1186\/s13075-015-0787-y","article-title":"Diagnostic performance of measuring antibodies to the glycopeptidolipid core antigen specific to Mycobacterium avium complex in patients with rheumatoid arthritis: results from a cross-sectional observational study","volume":"17","author":"Hirose","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"2026101605073634100_rkag112-B15","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1080\/14397595.2017.1336866","article-title":"Biomarker for nontuberculous mycobacterial pulmonary disease in patients with rheumatoid arthritis: anti-glycopeptidolipid core antigen immunoglobulin A antibodies","volume":"28","author":"Iwata","year":"2018","journal-title":"Mod Rheumatol"},{"key":"2026101605073634100_rkag112-B16","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1038\/s41423-021-00694-9","article-title":"Reactivation of latent tuberculosis with TNF inhibitors: critical role of the beta 2 chain of the IL-12 receptor","volume":"18","author":"Robert","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"2026101605073634100_rkag112-B17","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ero.2025.10.003","article-title":"How should we manage patients with interferon-gamma release assay-positive results in rheumatology: assessing the risk and long-term prognosis of tuberculosis","volume":"1","author":"Nogi","year":"2025","journal-title":"EULAR Rheumatol Open"},{"key":"2026101605073634100_rkag112-B18","doi-asserted-by":"crossref","first-page":"e0306337","DOI":"10.1371\/journal.pone.0306337","article-title":"Is yearly interferon gamma release assay latent tuberculosis infection screening warranted among patients with rheumatological diseases on disease-modifying drugs in non-endemic settings?","volume":"19","author":"Palacios","year":"2024","journal-title":"PLoS One"},{"key":"2026101605073634100_rkag112-B19","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"key":"2026101605073634100_rkag112-B20","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"2026101605073634100_rkag112-B21","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","article-title":"An official ATS\/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases","volume":"175","author":"Griffith","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"2026101605073634100_rkag112-B22","first-page":"1021","article-title":"Waning of the specific interferon-gamma response after years of tuberculosis infection","volume":"11","author":"Mori","year":"2007","journal-title":"Int J Tuberc Lung Dis"},{"key":"2026101605073634100_rkag112-B23","doi-asserted-by":"crossref","first-page":"29325","DOI":"10.1038\/srep29325","article-title":"Diagnostic test accuracy of anti-glycopeptidolipid-core IgA antibodies for Mycobacterium avium complex pulmonary disease: systematic review and meta-analysis","volume":"6","author":"Shibata","year":"2016","journal-title":"Sci Rep"},{"key":"2026101605073634100_rkag112-B24","doi-asserted-by":"crossref","first-page":"106086","DOI":"10.1016\/j.rmed.2020.106086","article-title":"Clinical significance of anti-glycopeptidolipid-core IgA antibodies in patients newly diagnosed with Mycobacterium avium complex lung disease","volume":"171","author":"Matsuda","year":"2020","journal-title":"Respir Med"},{"key":"2026101605073634100_rkag112-B25","first-page":"44","article-title":"Use of glycopeptidolipid core antigen for serodiagnosis of mycobacterium avium complex pulmonary disease in immunocompetent patients","volume":"12","author":"Kitada","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"key":"2026101605073634100_rkag112-B26","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1164\/rccm.201002-0310OC","article-title":"Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems","volume":"182","author":"Prevots","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"2026101605073634100_rkag112-B27","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1016\/j.immuni.2023.10.008","article-title":"Sex hormone signaling and regulation of immune function","volume":"56","author":"Hoffmann","year":"2023","journal-title":"Immunity"},{"key":"2026101605073634100_rkag112-B28","doi-asserted-by":"crossref","first-page":"e18218","DOI":"10.1097\/MD.0000000000018218","article-title":"Association of HLA-DRB1 genotype with younger age onset and elder age onset rheumatoid arthritis in Japanese populations","volume":"98","author":"Oka","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"2026101605073634100_rkag112-B29","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/rheumatology\/ket449","article-title":"Are there differences between young- and older-onset early inflammatory arthritis and do these impact outcomes? An analysis from the CATCH cohort","volume":"53","author":"Arnold","year":"2014","journal-title":"Rheumatology (Oxford)"}],"container-title":["Rheumatology Advances in Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumap\/advance-article-pdf\/doi\/10.1093\/rap\/rkag112\/71027979\/rkag112.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumap\/article-pdf\/10\/4\/rkag112\/71027979\/rkag112.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumap\/article-pdf\/10\/4\/rkag112\/71027979\/rkag112.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:07:44Z","timestamp":1792141664000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumap\/article\/doi\/10.1093\/rap\/rkag112\/8790344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,9,21]]}},"URL":"https:\/\/doi.org\/10.1093\/rap\/rkag112","relation":{},"ISSN":["2514-1775"],"issn-type":[{"value":"2514-1775","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026]]},"published":{"date-parts":[[2026]]},"article-number":"rkag112"}}